The Open Nutraceuticals Journal


ISSN: 1876-3960 ― Volume 8, 2015

Randomized, Double Blind, Placebo Controlled Trial of Hydrosoluble Ubiquinol and Carnitine in Patients with Heart Failure: Longterm Follow up Results in the Tishcon Study

The Open Nutraceuticals Journal, 2008, 1: 1-6

Viola Mechirova, Adarsh Kumar, Ram B. Singh, Rakesh Sharma, Pronobesh Chattopadhyay, Mohammad A. Niaz, Amar S. Thakur, Jan Fedacko, Daniel Pella, Lekh Juneja

Halberg Hospital and Research Institute, Civil Lines, Moradabad-10(UP)244001, India.

Electronic publication date 6/11/2008
[DOI: 10.2174/1876396000801010001]



Carnitine and coenzyme Q10 are important for myocardial- mitochondrial function, and are deficient in patients with congestive heart failure. It is possible that supplementation with ubiquinol + l- carnitine may be protective among these patients, which may improve the quality of life and morbidity in heart failure.

Subjects and Methods:

In this controlled trial, the effects of carni Q-gel (L-carnitine fumarate 2250mg/day+hydrosoluble reduced ubiquinol 270mg/day) were examined for 15 months, in 31 (intervention group A) and another 31(control group B) patients with heart failure. Hospitalization due to worsening of heart failure, heart transplantation, and deaths were the combined endpoints.


Echo cardiographic ejection fraction was lower at baseline (38.8±7.6 v/s 39.3±6.7%) among both the group of patients, indicating class II- IV heart failure.

Baseline serum CoQ10 (0.21±0.11 v/s 0.19+0.10ug/ml) was low, however, after 12 weeks, serum CoQ showed a significant increase in the carniqgel group compared to the control group (2.7±1.2 v/s 0.76±0.14 ug/ml). After treatment for 12 months, the quality of life visual analogous scale revealed that dyspnea, palpitation and fatigue and NYHA class II-III-IV, which were present at rest, in all the patients, at baseline, showed beneficial effects in the intervention group compared to the placebo group. Six minutes walk test showed that there was a significant greater benefit in walking in the intervention group (215±17.6 v/s 281±20.6, P<0.02) compared to the placebo group (218.4±17.6 v/s 245.7±17.1, P<0.05). A change in the symptom scale showed that majority of the patients had improvement in the intervention group compared to the control group respectively (28 v/s 12 patients, P<0.02). The deaths (3 vs 8) and hospitalizations due to worsening of heart failure (2 vs 11) among intervention and control group respectively, were significantly lower in the carniqgel group compared to the control group (5 vs 19, P<0.02). Five patients had nausea and vomiting, which were controlled with symptomatic treatment. Treatment with carniqgel was stopped after 12 months. Follow up after another 3 months (total 15 months) revealed that there was a worsening of NYHA class heart failure, as well as in the quality of life symptom scale and physical performance, assessed by 6-min walk test. There was a nonsignificant increase in hospitalizations in the intervention group after cessation of carniqgel softsules, compared to hospitalizations during the last 3 months.


The findings indicate that treatment with ubiquinol +L-carnitine fumarate can cause a significant improvement in the quality of life, exercise capacity, as well as NYHA heart failure, which became worst after cessation of CoQ. There was a significant greater benefit in combined endpoints (hospitalization and deaths) in the intervention group than in the control group.

Download PDF

Track Your Manuscript:


"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."

Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."

Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."

Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."

Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."

Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."

Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."

Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."

J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."

Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."

Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."

Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."

Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."

Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."

M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."

Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."

Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."

Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."

Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."

Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."

Jih Ru Hwu
(National Central University, Taiwan)

Browse Contents

Webmaster Contact:
Copyright © 2022 Bentham Open